Recruiting COVID-19 Studies in La Mesa
A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults
The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID-19 Vaccine, mRNA; 2024-2025 Formula), a currently a...
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
The purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called variant-adapted BNT162b2 RNA-based vaccine) in healthy ch...
About COVID-19 Clinical Trials in La Mesa
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus that primarily affects the respiratory system. Long COVID (PASC) involves persistent symptoms weeks or months after initial infection. Treatment includes antiviral medications, monoclonal antibodies, and supportive care.
There are currently 2 covid-19 clinical trials recruiting participants in La Mesa, CA. These studies are seeking a combined 14,308 participants. Research is being sponsored by CyanVac LLC, BioNTech SE. Clinical trial participation is free and participants receive study-related medical care at no cost.
COVID-19 Clinical Trials in La Mesa — FAQ
Are there covid-19 clinical trials in La Mesa?
Yes, there are 2 covid-19 clinical trials currently recruiting in La Mesa, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in La Mesa?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the La Mesa research site will contact you about next steps.
Are clinical trials in La Mesa free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many La Mesa studies also compensate for your time and travel.
What covid-19 treatments are being tested?
The 2 active trials in La Mesa are testing new therapies including novel drugs, biologics, and treatment approaches for covid-19.
Data updated March 2, 2026 from ClinicalTrials.gov